Literature DB >> 18347933

BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma.

Nicolas Kozakowski1, Afschin Soleiman, Johannes Pammer.   

Abstract

BMI-1 regulates cell proliferation and differentiation, is involved in stem cell maintenance and can act as an oncogene. We investigated BMI-1 expression in healthy normal kidney and in 77 renal tumours by immunohistochemistry, and correlated it with tumour differentiation. BMI-1 could regularly be demonstrated in distal tubules and in Bowman's capsule, whereas it was mostly lacking in proximal tubules, indicating that it may rather be a differentiation marker of different renal cell populations than a stem cell marker. In contrast to previous studies demonstrating a correlation between BMI-1 expression and malignancy, we showed that its expression was inversely correlated with the differentiation grade of clear cell carcinoma. Furthermore, despite their different biologies, BMI-1 was strongly expressed in both papillary carcinomas and oncocytomas. Thus, in renal clear cell carcinomas BMI-1 is rather a differentiation marker lost in carcinomas with high malignancy than an oncogene involved in tumour progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347933     DOI: 10.1007/s12253-008-9006-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

Review 1.  Stem cells in the kidney.

Authors:  Qais Al-Awqati; Juan A Oliver
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

2.  The renal papilla is a niche for adult kidney stem cells.

Authors:  Juan A Oliver; Omar Maarouf; Faisal H Cheema; Timothy P Martens; Qais Al-Awqati
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 3.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

4.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 5.  PcG complexes and chromatin silencing.

Authors:  V Pirrotta
Journal:  Curr Opin Genet Dev       Date:  1997-04       Impact factor: 5.578

6.  Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.

Authors:  R H J Breuer; P J F Snijders; G T Sutedja; R G A B Sewalt; A P Otte; P E Postmus; C J L M Meijer; F M Raaphorst; E F Smit
Journal:  Lung Cancer       Date:  2005-06       Impact factor: 5.705

7.  Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.

Authors:  Margarita Sánchez-Beato; Esther Sánchez; Joaquín González-Carreró; Manuel Morente; Ana Díez; Lydia Sánchez-Verde; María Carmen Martín; Juan C Cigudosa; Miguel Vidal; Miguel A Piris
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

8.  Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.

Authors:  Carly Leung; Merel Lingbeek; Olga Shakhova; James Liu; Ellen Tanger; Parvin Saremaslani; Maarten Van Lohuizen; Silvia Marino
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

9.  Function of the Polycomb protein is conserved in mice and flies.

Authors:  J Müller; S Gaunt; P A Lawrence
Journal:  Development       Date:  1995-09       Impact factor: 6.868

10.  The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain.

Authors:  A J Saurin; C Shiels; J Williamson; D P Satijn; A P Otte; D Sheer; P S Freemont
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

View more
  8 in total

1.  Significance of cyclooxygenase-2, prostaglandin E2 and CD133 levels in sunitinib-resistant renal cell carcinoma.

Authors:  Lei Luo; Ye Liang; Xuemei Ding; Xiaocheng Ma; Guiming Zhang; Lijiang Sun
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

2.  High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma.

Authors:  Qilai Long; Li Liu; Yu Xia; Qi Bai; Jiajun Wang; Jiejie Xu; Jianming Guo
Journal:  Tumour Biol       Date:  2015-05-14

3.  Regeneration of glomerular podocytes by human renal progenitors.

Authors:  Elisa Ronconi; Costanza Sagrinati; Maria Lucia Angelotti; Elena Lazzeri; Benedetta Mazzinghi; Lara Ballerini; Eliana Parente; Francesca Becherucci; Mauro Gacci; Marco Carini; Enrico Maggi; Mario Serio; Gabriella Barbara Vannelli; Laura Lasagni; Sergio Romagnani; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

Review 4.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

5.  Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma.

Authors:  Xiao-Ting He; Xiu-Feng Cao; Lv Ji; Bin Zhu; Jin Lv; Dong-Dong Wang; Pei-Hua Lu; Heng-Guan Cui
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

6.  Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?

Authors:  Ana L Teixeira; Francisca Dias; Mónica Gomes; Mara Fernandes; Rui Medeiros
Journal:  J Kidney Cancer VHL       Date:  2014-12-24

7.  Possible mechanisms of kidney repair.

Authors:  Paola Romagnani; Raghu Kalluri
Journal:  Fibrogenesis Tissue Repair       Date:  2009-06-26

Review 8.  Toward the identification of a "renopoietic system"?

Authors:  Paola Romagnani
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.